US Sexually-Transmitted Diseases Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023
About This Report
This new 280-page report presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals, Commercial, Physician Offices, and Public Health Labs.
In addition to market share and sales forecasts, the report:
- Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used
for STD testing;
- Profiles key suppliers and potential market entrants developing innovative
technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies,
market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the proprietary data files was conducted.
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Papillomavirus (HPV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
IX. USA: Market Size, Growth and Major Suppliers
Sales and Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako
List Of Tables
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
U.S.A.
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Chancroid Diagnostics Sales by Major Supplier
U.S.A.
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Chlamydia Diagnostics Sales by Major Supplier
U.S.A.
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Herpes Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Syphilis Testing Market Diagnostics Sales
by Major Supplier
US Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
US Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging OpportunitiesThis new report from contains 567 pages
USD 3450 View Report2024 US Hospital Microbiology Analyzers and Consumables Tests Supplier Shares and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
2024 US Hospital Microbiology Analyzers and Consumables for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities This new report from contains
USD 3450 View Report2021 US Sexually-Transmitted Diseases (STD) Diagnostic Testing Market Assessment--Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts--Latest Technologies and Instrumentation
About This ReportThis new 280-page report from LeadingMarketResearch.com presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus
USD 2500 View Report2021 UK Sexually-Transmitted Diseases (STD) Diagnostic Testing Market Assessment--Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts--Latest Technologies and Instrumentation
About This ReportThis new 280-page report from LeadingMarketResearch.com presents detailed analysis of the U.K. STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus
USD 1850 View ReportFill The Form For Sample Request